Ranolazine Extended Release 1000mg Tablet in PCD pharma franchise in Hyderabad

Ranolazine Extended Release 1000mg Tablet in pharmaceutical manufacturing company in Mumbai

Ranolazine Extended Release 1000mg Tablet in antianginal pharma franchise in Pune

Ranolazine Extended Release 1000mg Tablet in pharma suppliers in Delhi

Ranolazine Extended Release 1000mg Tablet in pharma export companies in Kolkata
Ranfoli SR 1000 Tablet in cardiac care pharma franchise opportunities in Bengaluru

Ranfoli SR 1000 Tablet

Composition : Ranolazine Extended Release 1000mg Tablets

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹145/-

Please Contact For Best Price

Ranfoli SR 1000 Tablet contains Ranolazine 1000mg in an extended-release formulation, designed to provide sustained control of chronic angina symptoms. Ranolazine works by improving the efficiency of oxygen use in heart muscles without significantly affecting heart rate or blood pressure. It acts by inhibiting the late sodium current in cardiac cells, thereby reducing intracellular calcium overload and improving myocardial relaxation and perfusion. This makes it an effective option for patients who require long-term angina management or who are not responding adequately to conventional therapies.


Read More

About the Product

Ranfoli SR 1000 Tablet contains Ranolazine 1000mg in an extended-release formulation, designed to provide sustained control of chronic angina symptoms. Ranolazine works by improving the efficiency of oxygen use in heart muscles without significantly affecting heart rate or blood pressure. It acts by inhibiting the late sodium current in cardiac cells, thereby reducing intracellular calcium overload and improving myocardial relaxation and perfusion. This makes it an effective option for patients who require long-term angina management or who are not responding adequately to conventional therapies.


Most patients tolerate Ranolazine well. However, some may experience dizziness, constipation, nausea, or headache. Rare but serious side effects can include QT interval prolongation or renal function changes, particularly in patients with pre-existing cardiac or renal conditions.

Ranfoli SR 1000 is indicated for the treatment of chronic stable angina in adults. It helps reduce the frequency of angina attacks, improve exercise tolerance, and decrease the need for nitrate medications. It is often used as an adjunct to other anti-anginal drugs like beta-blockers or calcium channel blockers.

Ranolazine should be used strictly under medical supervision. It is not suitable for use during acute angina attacks. Caution is advised in patients with hepatic impairment, renal dysfunction, or those taking QT-prolonging drugs. Avoid grapefruit juice while on this medication.

Store in a cool, dry place below 25°C. Protect from light and moisture. Keep out of reach of children.

Get in Touch